Pilot study competition
Pilot study competition
Pilot study competition
Dear colleagues,
Thank you for taking the time to enter our inaugural abstract competition!
We were overwhelmed by the number of entries we received, and the scientific quality of each of the abstracts.
Ultimately, one abstract stood out from the rest, and we are pleased to announce that Jesse Huang for the Center of Molecular Medicine at Karolinska Institute is the winner of a free pilot study combining our in-house targeted metabolomics with Olink’s Target 96 panel technology.
We would like to take this opportunity to congratulate Jesse, and once again thank you all for participating.
Sincerely,
Adrian McCann
*Competitions terms and conditions apply:
- The pilot study will include the analyses of 88 plasma or serum samples across an Olink Target 96 or 48 panel and Bevital platform of choice.
- Participants will be required to submit a 250 word (<1500 characters) abstract by the 31st October 2023 describing their research, detailing background, research question(s) or objective(s), pilot study design, and chosen Olink panel and Bevital platform.
- Winning abstract will be announced on 14th November 2023.
- Winning client will be required to arrange and cover cost of shipping samples to Bevital. If necessary, cost of returning samples must also be covered by client.
- Confidentiality — Both Bevital and the client agree to maintain the confidentiality of any proprietary or confidential information shared within the submitted abstract and during the provision of the services. Bevital shall not disclose any test results, methodologies, or data to third parties without the prior written consent of the client.
- Ownership of Data — the client retains ownership of all data, results, and reports generated as a result of the services. Bevital may use de-identified and aggregated data for internal quality procedures.
- Warranty — Bevital agrees to perform the laboratory services specified in the competition in accordance with industry standards performed by qualified personnel in a professional and competent manner, and the client acknowledges that results may vary due to the nature of scientific testing and analysis.
- Force Majeure — Neither party shall be liable for any failure or delay in performing its obligations under this agreement due to circumstances beyond its reasonable control.